OTCMKTS:FLACU Frazier Lifesciences Acquisition (FLACU) Stock Price, News & Analysis $9.50 +0.23 (+2.48%) As of 11/22/2022 Add Share Share Stock Analysis Stock Analysis About Frazier Lifesciences Acquisition Stock (OTCMKTS:FLACU) Get FLACU alerts:Sign Up Key Stats Today's Range$8.07▼$10.8050-Day Range$9.50▼$9.5052-Week Range$8.07▼$10.80Volume18,300 shsAverage Volume13,949 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Frazier Lifesciences Acquisition Corp. is a special purpose acquisition company (SPAC) formed to identify and complete a business combination with a company in the life sciences sector. Unlike an operating pharmaceutical or biotechnology company, it was established primarily to raise capital through a public offering and pursue a merger, acquisition, or similar transaction. The company’s intended investment focus includes businesses developing pharmaceutical products, biotechnology platforms, medical technologies, and other life sciences products or services. It does not appear to have its own commercial product portfolio, manufacturing operations, or established customer geography apart from activities related to evaluating potential acquisition targets. Frazier Lifesciences Acquisition Corp. was associated with Frazier Life Sciences, an investment firm focused on the healthcare and life sciences industries. Publicly available information provides limited detail about the company’s operating activities and leadership beyond its SPAC structure, and its ultimate business-combination status should be verified through current regulatory filings.AI Generated. May Contain Errors. Read More Receive FLACU Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Frazier Lifesciences Acquisition and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. FLACU Stock News HeadlinesFrazier Life Sciences Acquisition Corp. II Announces Completion of $75,000,000 Initial Public OfferingOctober 15, 2026 | finance.yahoo.comFrazier Life Sciences Appoints Gordon Empey as Chief Operating OfficerMay 1, 2025 | tmcnet.comThe next convergence is hereIn 2006, a flooded mine at Cigar Lake sent uranium prices from the $50 range to $136 in eight months. This past May, flooding cut the supply route into the largest uranium complex on the planet, and in July Cigar Lake went down a second time. Gerardo Del Real calls this the Third Convergence Event and has backed three small companies positioned in front of it.November 17 at 1:00 AM | Digest Publishing (Ad)GlycoMimetics Enters Into Acquisition Agreement With Crescent BiopharmaOctober 31, 2024 | stockhouse.comGlycoMimetics enters acquisition agreement with Crescent BiopharmaOctober 29, 2024 | markets.businessinsider.comFrazier Lifesciences Acquisition Corporation (FLACU)August 5, 2022 | finance.yahoo.comNewAmsterdam Pharma Holding B.V. and Frazier Lifesciences Acquisition Corporation Announce Merger Agreement to Create Publicly Listed Company Focused on Transformative Oral Therapies for Major Cardiometabolic DiseasesJuly 25, 2022 | finance.yahoo.comAre Institutions Heavily Invested In Frazier Lifesciences Acquisition Corporation's (NASDAQ:FLAC) Shares?July 24, 2022 | finance.yahoo.comSee More Headlines FLACU Stock Analysis - Frequently Asked Questions How have FLACU shares performed this year? Frazier Lifesciences Acquisition's stock was trading at $9.50 at the beginning of the year. Since then, FLACU shares have increased by 0.0% and is now trading at $9.50. Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorN/A Industry N/A Sub-IndustryN/A Current SymbolOTCMKTS:FLACU CIK1828326 Webwww.frazierlifesciencesacquisition.com Phone206 621 7200FaxN/AEmployees4Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 10 Stocks Powering The Next AI Boom The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation. Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.Get This Free Report This page (OTCMKTS:FLACU) was last updated on 11/22/2022 by MarketBeat.com Staff. From Our PartnersPentagon magnet restrictions take effect January 1, 2027A NASDAQ-listed company has signed a term sheet outlining a potential 75-year agreement with the U.S. Army. It...OilPrice | SponsoredThe $40 trillion number nobody won on Tuesday will touchDemocrats took the House and Senate on election night, but the $40 trillion national debt and the $1 trillion ...Vault Metal | SponsoredTop Trader Reveals Stunning Black Friday DealOthers paid $500 for the Snapback Indicator. This Black Friday, it's available for just $7. Base Camp Tradi...Base Camp Trading | SponsoredToday's free pick (on me)Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one l...Behind the Markets | SponsoredDrop these 5 stocks before the market opens tomorrow!The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratin...Weiss Ratings | SponsoredYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | SponsoredYour father's savings lost half their value after 1971.On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Frazier Lifesciences Acquisition Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Frazier Lifesciences Acquisition With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.